Pfizer Covid vaccine provides partial protection against Omicron: Study
The yet-to-be peer-reviewed study, posted on the pre-print repository medRxiv recently, also found that considerable immunity is…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
Russia says Argentina approves Sputnik Light as standalone and booster vaccine
Argentina was one of the first countries to widely use Russia's Sputnik V COVID-19 vaccine, but delays in deliveries led the…
CHMP recommends EU approval of Actemra/RoActemra to treat patients with severe COVID-19
Actemra/RoActemra reduced the risk of death in patients with severe COVID-19, as evidenced by a review of four phase-III studies.…
Omicron: Parliamentary panel recommends evaluation of vaccines, more research for booster dose
The Parliamentary Standing Committee on Health, which presented its report recently, also said that concerns with regard to the…
Vaccine makers could make Omicron-specific booster, says Fauci
The US government is working with Moderna, Pfizer and J&J on multiple contingency plans, infectious disease expert Anthony…
Covishield current monthly production capacity 250-275 million doses, Covaxin 50-60 million doses,…
Both companies have achieved close to 90 per cent of present production capacity, Bharati Pravin Pawar, Minister of State for…
FDA expands authorisation of two monoclonal antibodies for treatment and post-exposure prevention…
Amlanivimab and Etesevimab are monoclonal antibodies that are specifically directed against the spike protein of SARS-CoV-2,…
UK study finds mRNA COVID-19 vaccines provide biggest booster impact
The study found that six out of the seven boosters examined enhanced immunity after initial vaccination with Pfizer-BioNTech's…
Novavax says it could start making Omicron-specific vaccine in January
Other vaccine makers including Moderna and Pfizer have also begun working on Omicron-tailored COVID-19 shots
Moderna COVID vaccine highly effective five months after second dose: Study
Funded by Moderna, the study included 352,878 recipients of two doses of the vaccine matched to 352,878 unvaccinated individuals…
ZyCoV-D to be used in seven states initially
The seven states are Bihar, Jharkhand, Maharashtra, Punjab, Tamil Nadu, Uttar Pradesh and West Bengal
Antibody drug works against COVID-19 Omicron variant: GSK
In a statement, the British drugmaker said that lab tests and a study on hamsters have demonstrated the Sotrovimab antibody…
Serum Institute seeks DCGI’s approval for Covishield as booster dose
In an application to DCGI, Prakash Kumar Singh, Director, Government and Regulatory Affairs, SII, cited that the UK’s MHRA has…
Covaxin and Covishield: The Sun and the Moon of Indian vaccine industry
Sudhir Phatak, Founder, Futurol Consultancy Services, explains how Bharat Biotech, like the sun, with its own R&D, has…
India’s Serum Institute delivers first Novavax shot through COVAX
The world's biggest vaccine maker exported 137,500 doses of Covovax, as it calls the shot, to the Southeast Asian country last…
Experts considering scientific evidence on need for booster dose against COVID
Responding to a query on the stand of the Indian Government on booster doses, Bharati Pravin Pawar, Union Minister of State for…
Bharat Biotech studying if Covaxin shot will work on Omicron
Covaxin was developed against the original Wuhan variant," according to a Bharat Biotech spokesperson
Celltrion signs COVID-19 antibody therapy supply deals with Europe
The first batch of 50,000 doses will be shipped to Europe this year and the company is in talks with 47 other nations including in…
Dr Reddy’s eyes Sputnik vaccine exports after domestic struggle
As the main Indian distributor of Sputnik, sold only on the private market, Dr Reddy's has struggled to compete with vaccines that…
Bharat Biotech resumes Covaxin exports
The company also said exports to additional countries will commence from December, according to a statement it shared on Twitter